Revance Therapeutics, Inc. (NASDAQ: RVNC) today announced a proposed underwritten public offering in which it will issue and sell approximately ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE